Dynamic analysis of tumor-associated immune cells in DEN-induced rat hepatocellular carcinoma

被引:13
作者
Song, Shasha [1 ]
Yuan, Pingfan [1 ]
Li, Peipei [1 ]
Wu, Huaxun [1 ]
Lu, Jingtao [1 ]
Wei, Wei [1 ]
机构
[1] Anhui Med Univ, Inst Clin Pharmacol, Key Lab Antiinflammatory & Immune Med, Minist Educ, Hefei 230032, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; N-nitrosodiethylamine; Dendritic cells; Regulatory B cells; Regulatory T cells; REGULATORY B-CELLS; INDEPENDENT DENDRITIC CELLS; LONG-TERM PROPAGATION; TGF-BETA; CANCER; PHENOTYPE; MICROENVIRONMENT; INTERLEUKIN-10; IMMUNOTHERAPY;
D O I
10.1016/j.intimp.2014.07.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatocellular carcinoma (HCC) is an aggressive disease with poor prognosis and limited methods to predict patient survival. Immune cells infiltrating tumors are known to impact tumor progression. Here, we analyzed the phenotype and function of dendritic cells (DCs), and the frequency of IL-10-producing regulatory B cells (Breg) and Foxp3(+) regulatory T cells (Treg) in different stages of N-nitrosodiethylamine (DEN)-induced rat HCC in order to understand their roles in this disease. 4 weeks following DEN treatment, no significant differences in CD80 and CD86 expression were found on DCs from HCC rats and normal rats but 12 and 16 weeks following DEN treatment, the expression of CD80, CD86 and MHCII on DCs of HCC rats was significantly decreased. We also found that the frequency of IL-10-producing Breg and CD4(+)CD25(+)Foxp3(+) Treg in HCC rats was obviously increased during all of these three stages. In addition, the bone-marrow derived DCs (BMDCs) from HCC rats displayed lower ability in activating T cells and an increase in IL-10 secretion. No differences in IL-12 level and endocytosis ability were found on BMDCs from HCC rats and normal rats. Our results suggest that the dysfunction of DCs and the increase of IL-10-producing Breg and Foxp3(+) Treg might play important roles in HCC progression. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:392 / 399
页数:8
相关论文
共 35 条
[1]   Harnessing dendritic cells in cancer [J].
Apetoh, Lionel ;
Locher, Clara ;
Ghiringhelli, Francois ;
Kroemer, Guido ;
Zitvogel, Laurence .
SEMINARS IN IMMUNOLOGY, 2011, 23 (01) :42-49
[2]   Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets [J].
Beckebaum, S ;
Zhang, X ;
Chen, X ;
Yu, ZY ;
Frilling, A ;
Dworacki, G ;
Grosse-Wilde, H ;
Broelsch, CE ;
Gerken, G ;
Cicinnati, VR .
CLINICAL CANCER RESEARCH, 2004, 10 (21) :7260-7269
[3]   Dendritic Cells The Tumor Microenvironment and the Challenges for an Effective Antitumor Vaccination [J].
Benencia, Fabian ;
Sprague, Leslee ;
McGinty, John ;
Pate, Michelle ;
Muccioli, Maria .
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2012,
[4]   Regulatory B cells play a key role in immune system balance [J].
Berthelot, Jean-Marie ;
Jamin, Christophe ;
Amrouche, Kahina ;
Le Goff, Benoit ;
Maugars, Yves ;
Youinou, Pierre .
JOINT BONE SPINE, 2013, 80 (01) :18-22
[5]   Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients [J].
Butterfield, Lisa H. ;
Economou, James S. ;
Gamblin, T. Clark ;
Geller, David A. .
JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
[6]   Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis [J].
Carter, Natalie A. ;
Rosser, Elizabeth C. ;
Mauri, Claudia .
ARTHRITIS RESEARCH & THERAPY, 2012, 14 (01)
[7]   The Janus face of dendritic cells in cancer [J].
Chaput, N. ;
Conforti, R. ;
Viaud, S. ;
Spatz, A. ;
Zitvogel, L. .
ONCOGENE, 2008, 27 (45) :5920-5931
[8]   Immunosuppression induced by immature dendritic cells is mediated by TGF-β/IL-10 double-positive CD4+ regulatory T cells [J].
Cools, N. ;
Van Tendeloo, V. F. I. ;
Smits, E. L. J. M. ;
Lenjou, M. ;
Nijs, G. ;
Van Bockstaele, D. R. ;
Berneman, Z. N. ;
Ponsaerts, P. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2008, 12 (02) :690-700
[9]   Increased Frequency of Foxp3+Regulatory T Cells in Mice with Hepatocellular Carcinoma [J].
Du, Yong ;
Chen, Xin ;
Huang, Zhi-Ming ;
Ye, Xiao-Hua ;
Niu, Qing .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) :3815-3819
[10]   Increased Frequency of CD4+CD25highFoxP3+ Regulatory T Cells in Patients with Hepatocellular Carcinoma [J].
Feng, Xi ;
Li, Bo ;
Ye, Hui ;
Long, Dan .
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2011, 59 (04) :309-314